Thousand Oaks Biologics Inc. (TOBio) and GeneQuantum Healthcare (Suzhou) Co., Ltd. (GQ) are pleased to announce that they have formed a strategic partnership focusing on the CMC development of ADC products with a core conjugation technology for more stable drug candidates. This press release features multimedia. View the full release…Read More
Thousand Oaks Biologics and GeneQuantum Healthcare Signed A Strategic Partnership Agreement for ADC Drug Development
